BR9916774A - Derivados de imidazo[4,5-c]piridina-4-ona - Google Patents

Derivados de imidazo[4,5-c]piridina-4-ona

Info

Publication number
BR9916774A
BR9916774A BR9916774-3A BR9916774A BR9916774A BR 9916774 A BR9916774 A BR 9916774A BR 9916774 A BR9916774 A BR 9916774A BR 9916774 A BR9916774 A BR 9916774A
Authority
BR
Brazil
Prior art keywords
pyridine
derivatives
imidazo
deimidazo
decoagulation
Prior art date
Application number
BR9916774-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Werner Mederski
Horst Juraszyk
Hanns Wurziger
Christostsaklakidis
Dieter Dorsch
Sabine Bernotat-Danielowski
Guidomelzer
Soheila Anzali
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR9916774A publication Critical patent/BR9916774A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR9916774-3A 1999-01-08 1999-12-21 Derivados de imidazo[4,5-c]piridina-4-ona BR9916774A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19900471A DE19900471A1 (de) 1999-01-08 1999-01-08 Imidazo[4,5c]-pyridin-4-on-derivate
PCT/EP1999/010236 WO2000040583A2 (de) 1999-01-08 1999-12-21 Imidazo[4,5-c]-pyridin-4-on-derivate

Publications (1)

Publication Number Publication Date
BR9916774A true BR9916774A (pt) 2001-10-30

Family

ID=7893790

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916774-3A BR9916774A (pt) 1999-01-08 1999-12-21 Derivados de imidazo[4,5-c]piridina-4-ona

Country Status (16)

Country Link
EP (1) EP1149099A2 (de)
JP (1) JP2002534429A (de)
KR (1) KR20010086085A (de)
CN (1) CN1333772A (de)
AR (1) AR022220A1 (de)
AU (1) AU3041700A (de)
BR (1) BR9916774A (de)
CA (1) CA2357771A1 (de)
CZ (1) CZ20012407A3 (de)
DE (1) DE19900471A1 (de)
HU (1) HUP0105054A3 (de)
NO (1) NO20013384L (de)
PL (1) PL349341A1 (de)
SK (1) SK9442001A3 (de)
WO (1) WO2000040583A2 (de)
ZA (1) ZA200106454B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE280171T1 (de) 1998-12-23 2004-11-15 Bristol Myers Squibb Pharma Co Stickstoffhaltige heterobicyclen als faktor-xa- hemmer
JP2004501918A (ja) * 2000-06-23 2004-01-22 ブリストル−マイヤーズ スクイブ ファーマ カンパニー Xa因子阻害剤としての1−(ヘテロアリール−フェニル)−縮合ピラゾール誘導体
EP1414449A4 (de) 2001-05-22 2005-04-06 Bristol Myers Squibb Co Bizyklische faktor-xa-hemmer
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
GB0225399D0 (en) * 2002-10-31 2002-12-11 Merck Sharp & Dohme Therapeutic agents
PT1569912E (pt) 2002-12-03 2015-09-15 Pharmacyclics Llc Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia
AU2004309390B2 (en) 2003-12-22 2011-06-02 Gilead Sciences, Inc. Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment
JP2008524335A (ja) 2004-12-21 2008-07-10 ギリアド サイエンシズ, インコーポレイテッド イミダゾ[4,5−c]ピリジン化合物および抗ウイルス処置法
JP2009501187A (ja) * 2005-07-15 2009-01-15 エフ.ホフマン−ラ ロシュ アーゲー 新規なヘテロアリール縮合環式アミン
EP1942898B2 (de) 2005-09-14 2014-05-14 Takeda Pharmaceutical Company Limited Dipeptidyl-peptidase-hemmer zur behandlung von diabetes
JP5122462B2 (ja) 2005-09-16 2013-01-16 武田薬品工業株式会社 ジペプチジルペプチダーゼ阻害剤
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
ES2339298T3 (es) 2006-07-07 2010-05-18 Gilead Sciences, Inc. Compuesto de piridazina novedoso y uso del mismo.
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
UA99466C2 (en) 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Crystalline pyridazine compound
JP6689821B2 (ja) * 2014-08-12 2020-04-28 シンジェンタ パーティシペーションズ アーゲー 硫黄含有置換基を有する殺有害生物的に活性な複素環式誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW219935B (de) * 1991-12-25 1994-02-01 Mitsubishi Chemicals Co Ltd
AU741766B2 (en) * 1997-12-01 2001-12-06 Merck & Co., Inc. Thrombin inhibitors

Also Published As

Publication number Publication date
AU3041700A (en) 2000-07-24
ZA200106454B (en) 2002-11-06
JP2002534429A (ja) 2002-10-15
WO2000040583A3 (de) 2000-09-21
HUP0105054A3 (en) 2002-12-28
EP1149099A2 (de) 2001-10-31
NO20013384D0 (no) 2001-07-06
WO2000040583A2 (de) 2000-07-13
SK9442001A3 (en) 2002-05-09
CN1333772A (zh) 2002-01-30
KR20010086085A (ko) 2001-09-07
CA2357771A1 (en) 2000-07-13
NO20013384L (no) 2001-07-06
HUP0105054A2 (hu) 2002-05-29
AR022220A1 (es) 2002-09-04
PL349341A1 (en) 2002-07-15
DE19900471A1 (de) 2000-07-13
CZ20012407A3 (cs) 2001-12-12

Similar Documents

Publication Publication Date Title
BR9813477A (pt) Derivados de benzamidina
BR9812699A (pt) Derivados de benzamidina
BR9916774A (pt) Derivados de imidazo[4,5-c]piridina-4-ona
BR0116804A (pt) Derivados fenìlicos
BR9917080A (pt) Composto, composição farmacêutica, uso do composto e método de tratamento ou prevenção de uma disfunção tromboembólica
BRPI0307057B8 (pt) compostos 2-(piridin-2-ilamino)-pirido[2,3-d]pirimidin-7-onas
BR0208891A (pt) Derivados de dihidro-benzo[b]-[1,4]diazepin-2-ona como antagonistas de mglur2 ii
BRPI0409366A (pt) compostos de pirimido
BR0109703A (pt) Derivados de piperazina
SE9904508D0 (sv) New compounds
NZ517758A (en) Pyrazolopyrimidines useful as therapeutic agents
CO4910133A1 (es) Antagonistas de 5-h[1f]
BRPI0412291A (pt) antagonistas duplos de nka/nk3 para o tratamento de esquizofrenia
DK1222195T3 (da) Hidtil ukendte thiazolo[4,5-d]pyrimidinforbindelser
AU2002246728A1 (en) Carboline derivatives
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
BR0309463A (pt) Derivados de 1,2,3,4,7,8-hexaidro-6h-[1,4]diazepino[6,7,1-ij]quinolina como agentes antipsicóticos e antiobesidade
AU2002213421A1 (en) Condensed pyridoindole derivatives
BR0210531A (pt) Derivados de ácido sulfÈnico
IS7839A (is) 4-oxó-1-(3-setið fenýl-1,4-díhýdró-1,8-naftýridín-3-karboxamíð fosfódíesterasa-4 hindrar
BR0207166A (pt) Composto, e, composição farmacêutica
SE0302756D0 (sv) Novel Compounds
AU2002213419A1 (en) Condensed pyridoindole derivatives
BR0008608A (pt) Derivados de pirazol-3-ona
NO975028D0 (no) Piperazinoderivater som neurokininantagonister

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]